Neuland Laboratories Price (NEULANDLAB.NS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

12,829,889

(0)%

Neuland Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $5540.1-18100
  • Market Cap 141.80B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

  • ceo: Mr. Davuluri Sucheth Rao
  • IPO Date: October, 13, 2008
  • Country: IN
  • Currency: INR
  • Headquaters: No Data
  • Employees: 1643

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation